hc1 Insights, Inc.
PrivateLast Round
Early Funding
Jan 13, 2025
Total Funding Raised
$44.85M
Company Overview
hc1 is a bioinformatics company that provides a cloud-based platform for precision testing and prescribing. The platform organizes live data, including lab results, genomics, and medications, to create personalized patient profiles. Its solutions aim to ensure patients receive the correct diagnostic tests and prescriptions, helping to optimize patient care, improve operations, and reduce costs for health systems, laboratories, and health plans. The company's offerings include products for healthcare CRM, lab operational analytics, and test utilization. In 2024, hc1 acquired Accumen, a healthcare performance consulting company, to enhance its ability to transform diagnostic labs into strategic assets for health systems.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Business Intelligence, Data Integration, Vertical SaaS, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
hc1 Insights, Inc. Comps
Public and private peers based on sector, stage, and business model.
hc1 Insights, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 13, 2025 | ||||
| Series B Extension | Aug 22, 2018 | ||||
| Series B | Apr 10, 2018 | ||||
| Debt | Oct 19, 2015 | ||||
| Series B Extension | Oct 19, 2015 | ||||
Series B | Mar 12, 2015 |
Key People
Founding team and executive leadership
hc1 Insights, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevate Ventures | Series B, Series B Extension |
| Health Cloud Capital | Series B, Early Funding, Series B Extension |
| Indiana 21st Century Research and Technology Fund | Seed |
| Arsenal Capital Partners | Early Funding |
| A1 Health Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2025
Launched HerCare module for anemia risk in pregnancy.
- Apr 1, 2025
Targeting over $100 million in revenue.
hc1 Insights, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about hc1 Insights, Inc.'s valuation, stock price, and market status.
